MEDINDIA
English
हिन्दी
Español
français
中文
Alzheimer’s disease treatment gantenerumab is set to generate $2.2bn by 2030, as the first subcutaneously administered therapy to enter the global market.
Alzheimer’s disease - Causes, Symptoms, Diagnosis, Stages, Types, Prevention, Prognosis & Treatment
Alzheimer's disease is a progressive neurodegenerative disease affecting memory and thinking and making the person increasingly dependent on others.
Alzheimer's disease is a progressive neurodegenerative disease affecting memory and thinking and making the person increasingly dependent on others.
TOP INSIGHT
Gantenerumab can be a promising late-stage disease-modifying therapy (DMT) for Alzheimer’s disease.
Aduhelm, lecanemab, and donanemab are intravenously administered mAbs, whereas gantenerumab would become the first subcutaneously administered mAb for AD.
This alternative route of administration provides a point of difference, and a potential competitive edge for gantenerumab as subcutaneous administration could allow for at-home administration. However, there are still challenges for gantenerumab if it is to succeed as an AD treatment.
Dementia - Types, Causes, Symptoms, Diagnosis, Treatment
Dementia has become a very big concern as we have an aging population across the world. Dementia is also terrifying to us because of its disturbing symptoms and limited treatment options.
Dementia has become a very big concern as we have an aging population across the world. Dementia is also terrifying to us because of its disturbing symptoms and limited treatment options.
Additionally, previous clinical trial failures have cast some doubt over the efficacy of gantenerumab. However, this does not mean that gantenerumab will fail to reach the market, following the precedent set by the FDA with the approval of Aduhelm.
Alzheimer�s Disease Risk Increases With Body Weight
An increase in body weight is associated with a decrease in brain activity and blood flow. The changes can be virtually assessed by neuroimaging in brain regions, including those influenced by Alzheimer's disease pathology such as the hippocampus.
An increase in body weight is associated with a decrease in brain activity and blood flow. The changes can be virtually assessed by neuroimaging in brain regions, including those influenced by Alzheimer's disease pathology such as the hippocampus.
Source-Medindia
Diet and Alzheimer's Disease
Alzheimer's begins with forgetfulness, but over time affects speech and coordination along with drastic behavioral changes. The right diet may lower your risk by 40%. So isn't a diet change worth it?
Alzheimer's begins with forgetfulness, but over time affects speech and coordination along with drastic behavioral changes. The right diet may lower your risk by 40%. So isn't a diet change worth it?
Email
